Press Release
<< Back
EMCORE Reports Fiscal 2024 Second Quarter Results
“Lower-than-expected revenue in the March quarter was primarily due to product shipment delays and declining revenue from our
Three Months Ended | |||
+increase/ | |||
2Q24 | 1Q24 | -decrease | |
Revenue | - |
||
Gross margin | 17% | 25% | -8% |
Operating expenses | |||
Net loss on continuing operations | ( |
( |
- |
Net loss on continuing operations per share, basic and diluted | ( |
( |
- |
Non-GAAP gross margin (a) | 15% | 29% | -14% |
Non-GAAP operating expenses (a) | |||
Non-GAAP net loss on continuing operations (a) | ( |
( |
- |
Non-GAAP net loss on continuing operations per share, basic and diluted (a) | ( |
( |
- |
Adjusted EBITDA | ( |
( |
- |
Ending cash and cash equivalents | - |
||
Line of credit and loan payable | - |
||
(a) Please refer to the schedules at the end of this press release for GAAP to non-GAAP reconciliations and other information related to non-GAAP financial measures. |
Business Outlook
The Company expects revenues for the fiscal third quarter (3Q24) ending
CEO Departure
The Company also announced that its CEO,
Chairman of the Board,
Conference Call
The Company will host a conference call to discuss its financial results on
About EMCORE
Use of Non-GAAP Financial Measures
The Company conforms to
Management believes these supplemental non-GAAP measures reflect the Company’s core ongoing operating performance and facilitate comparisons across reporting periods. The Company uses these measures when evaluating its financial results and for planning and forecasting of future periods. We believe that these supplemental non-GAAP measures are also useful to investors in assessing our operating performance. While we believe in the usefulness of these supplemental non-GAAP measures, there are limitations. Our non-GAAP measures may not be reported by other companies in our industry and/or may not be directly comparable to similarly titled measures of other companies due to potential differences in calculation. We compensate for these limitations by using these non-GAAP measures as a supplement to GAAP and by providing the reconciliations to the most comparable GAAP measure.
The schedules at the end of this press release reconcile the Company’s non-GAAP measures to the most directly comparable GAAP measure. The adjustments share one or more of the following characteristics: (a) they are unusual and the Company does not expect them to recur in the ordinary course of its business, (b) they do not involve the expenditure of cash, (c) they are unrelated to the ongoing operation of the business in the ordinary course, or (d) their magnitude and timing is largely outside of the Company’s control. All of these items meet one or more of the characteristics listed above. The criteria that must be met for litigation-related expense to qualify as a non-GAAP measure is that it must be directly connected to active litigation that the Company infrequently encounters and is unrelated to the ongoing operations of the business in the ordinary course. All legal expenses related to the ordinary course of business are included in the non-GAAP results consistently for all reporting periods. The Company has, for all reporting periods disclosed in this press release, applied consistent rationale, method, and adjustments in reconciling non-GAAP measures to the most directly comparable GAAP measure, reflecting the Company’s core ongoing operating performance and facilitating comparisons across reporting periods that the Company uses when evaluating its financial results, planning and forecasting future periods, and that are useful to investors in assessing our performance.
Non-GAAP measures are not in accordance with or an alternative to GAAP, nor are they meant to be considered in isolation or as a substitute for comparable GAAP measures. Our disclosures of these measures should be read only in conjunction with our financial statements prepared in accordance with GAAP. Non-GAAP measures should not be viewed as a substitute for the Company’s GAAP results.
Forward-Looking Statements
The information provided herein may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 (“Exchange Act”). These forward-looking statements are based on our current expectations and projections about future events and financial trends affecting the financial condition of our business. Such forward-looking statements include, in particular, business outlook including expected revenue for 3Q24, our strategy and focus, goals of our restructuring committee, and statements about our future results of operations and financial position, plans, strategies, business prospects, changes, and trends in our business and the markets in which we operate.
These forward-looking statements may be identified by the use of terms and phrases such as “anticipates”, “believes”, “can”, “could”, “estimates”, “expects”, “forecasts”, “intends”, “may”, “plans”, “projects”, “targets”, “will”, and similar expressions or variations of these terms and similar phrases. Additionally, statements concerning future matters such as the development of new products, future growth, enhancements or technologies, sales levels, expense levels, and other statements regarding matters that are not historical are forward-looking statements. We caution that these forward-looking statements relate to future events or our future financial performance and are subject to business, economic, and other risks and uncertainties, both known and unknown, that may cause actual results, levels of activity, performance, or achievements of our business or our industry to be materially different from those expressed or implied by any forward-looking statements.
These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected, including without limitation, the following: (a) risks related to our ability to obtain capital; (b) risks related to the sale of our Chips business and Alhambra InP wafer fab assets, including without limitation the failure to achieve or fully realize the anticipated benefits of the transaction, third party costs incurred by the Company related to the transaction, and risks associated with any liabilities, assets or businesses retained by the Company in transaction; (c) any disruptions to the Company’s compliance with the terms of the Forbearance Agreement with
Forward-looking statements are based on certain assumptions and analysis made in light of our experience and perception of historical trends, current conditions, and expected future developments as well as other factors that we believe are appropriate under the circumstances. While these statements represent our judgment on what the future may hold, and we believe these judgments are reasonable, these statements are not guarantees of any events or financial results. All forward-looking statements in this press release are made as of the date hereof, based on information available to us as of the date hereof, and subsequent facts or circumstances may contradict, obviate, undermine, or otherwise fail to support or substantiate such statements. We caution you not to rely on these statements without also considering the risks and uncertainties associated with these statements and our business that are addressed in our filings with the
Condensed Consolidated Balance Sheets (unaudited) |
|||||||
(in thousands) | 2024 | 2023 | |||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 11,495 | $ | 26,211 | |||
Restricted cash | 495 | 495 | |||||
Accounts receivable, net of credit loss of |
13,901 | 15,575 | |||||
Contract assets | 8,097 | 8,402 | |||||
Inventory | 32,124 | 28,905 | |||||
Prepaid expenses | 3,721 | 4,612 | |||||
Other current assets | 397 | 922 | |||||
Assets held for sale | 3,552 | 7,264 | |||||
Total current assets | 73,782 | 92,386 | |||||
Property, plant, and equipment, net | 13,717 | 15,517 | |||||
Operating lease right-of-use assets | 20,051 | 21,564 | |||||
Other intangible assets, net | 11,258 | 12,245 | |||||
Other non-current assets | 2,189 | 2,201 | |||||
Total assets | $ | 120,997 | $ | 143,913 | |||
LIABILITIES and SHAREHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 8,591 | $ | 9,683 | |||
Accrued expenses and other current liabilities | 7,637 | 8,471 | |||||
Contract liabilities | 2,278 | 1,630 | |||||
Financing payable | — | 460 | |||||
Loan payable - current | 852 | 852 | |||||
Operating lease liabilities - current | 3,148 | 3,033 | |||||
Liabilities held for sale | 37 | 4,662 | |||||
Total current liabilities | 22,543 | 28,791 | |||||
Line of credit | 4,582 | 6,418 | |||||
Loan payable - non-current | 2,904 | 3,330 | |||||
Operating lease liabilities - non-current | 19,309 | 20,882 | |||||
Asset retirement obligations | 4,316 | 4,194 | |||||
Other long-term liabilities | 8 | 8 | |||||
Total liabilities | 53,662 | 63,623 | |||||
Commitments and contingencies | |||||||
Shareholders’ equity: | |||||||
Common stock, no par value, 100,000 shares authorized; 88,945 shares issued and 82,039 shares outstanding as of |
826,338 | 825,119 | |||||
(47,721 | ) | (47,721 | ) | ||||
Accumulated other comprehensive income | 350 | 350 | |||||
Accumulated deficit | (711,632 | ) | (697,458 | ) | |||
Total shareholders’ equity | 67,335 | 80,290 | |||||
Total liabilities and shareholders’ equity | $ | 120,997 | $ | 143,913 |
Condensed Consolidated Statements of Operations (unaudited) |
|||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||
(in thousands, except for per share data) | 2024 | 2023 | 2024 | 2023 | |||||||||||
Revenue | $ | 19,634 | $ | 24,250 | $ | 43,757 | $ | 44,229 | |||||||
Cost of revenue | 16,387 | 19,389 | 34,422 | 34,989 | |||||||||||
Gross profit | 3,247 | 4,861 | 9,335 | 9,240 | |||||||||||
Operating expense: | |||||||||||||||
Selling, general, and administrative | 6,037 | 9,089 | 12,646 | 18,378 | |||||||||||
Research and development | 3,726 | 4,882 | 7,335 | 9,097 | |||||||||||
Severance | 1,019 | — | 1,230 | 16 | |||||||||||
Impairment | 88 | — | 88 | — | |||||||||||
Loss (gain) on sale of assets | — | 24 | (31 | ) | (1,147 | ) | |||||||||
Total operating expense | 10,870 | 13,995 | 21,268 | 26,344 | |||||||||||
Operating loss | (7,623 | ) | (9,134 | ) | (11,933 | ) | (17,104 | ) | |||||||
Other expense: | |||||||||||||||
Interest expense, net | (67 | ) | (196 | ) | (76 | ) | (411 | ) | |||||||
Foreign exchange loss | — | (1 | ) | — | (1 | ) | |||||||||
Other income (expense) | 1 | 19 | (15 | ) | 126 | ||||||||||
Total other expense | (66 | ) | (178 | ) | (91 | ) | (286 | ) | |||||||
Loss from continuing operations before income tax expense | (7,689 | ) | (9,312 | ) | (12,024 | ) | (17,390 | ) | |||||||
Income tax expense from continuing operations | (86 | ) | (54 | ) | (114 | ) | (148 | ) | |||||||
Net loss from continuing operations | $ | (7,775 | ) | $ | (9,366 | ) | $ | (12,138 | ) | $ | (17,538 | ) | |||
Loss from discontinued operations | $ | (720 | ) | $ | (2,861 | ) | $ | (2,036 | ) | $ | (6,382 | ) | |||
Net loss | $ | (8,495 | ) | $ | (12,227 | ) | $ | (14,174 | ) | $ | (23,920 | ) | |||
Per share data: | |||||||||||||||
Net loss on continuing operations per share, basic and diluted | $ | (0.09 | ) | $ | (0.21 | ) | $ | (0.14 | ) | $ | (0.42 | ) | |||
Net loss on discontinued operations per share, basic and diluted | $ | (0.01 | ) | $ | (0.06 | ) | $ | (0.02 | ) | $ | (0.15 | ) | |||
Net loss per share, basic and diluted | $ | (0.10 | ) | $ | (0.27 | ) | $ | (0.16 | ) | $ | (0.58 | ) | |||
Weighted-average number of shares outstanding, basic and diluted | 89,239 | 45,240 | 89,113 | 41,356 |
Reconciliations of GAAP to Non-GAAP Financial Measures (unaudited) |
|||||||
Three Months Ended | |||||||
(in thousands, except for percentages) | 2Q24 | 1Q24 | |||||
Gross profit | $ | 3,247 | $ | 6,088 | |||
Gross margin | 17 | % | 25 | % | |||
Stock-based compensation expense | (341 | ) | 329 | ||||
Asset retirement obligation accretion | 61 | 61 | |||||
Intangible asset amortization | 494 | 494 | |||||
Variable compensation accrual adjustment | (599 | ) | — | ||||
Non-GAAP gross profit | $ | 2,862 | $ | 6,972 | |||
Non-GAAP gross margin | 15 | % | 29 | % |
Three Months Ended | |||||||
(in thousands) | 2Q24 | 1Q24 | |||||
Operating expense | $ | 10,870 | $ | 10,398 | |||
Stock-based compensation expense | (754 | ) | (519 | ) | |||
Impairment expense | (88 | ) | — | ||||
Severance expense | (1,019 | ) | (211 | ) | |||
Variable compensation accrual adjustment | 874 | — | |||||
Gain on sale of assets | — | 31 | |||||
Transition/M&A-related expense | (98 | ) | (158 | ) | |||
Litigation-related expense | — | 2 | |||||
Non-GAAP operating expense | $ | 9,785 | $ | 9,543 |
Three Months Ended | |||||||
(in thousands, except for per share data and percentages) | 2Q24 | 1Q24 | |||||
Net loss from continuing operations | $ | (7,775 | ) | $ | (4,363 | ) | |
Net loss from continuing operations per share, basic and diluted | $ | (0.09 | ) | $ | (0.05 | ) | |
Stock-based compensation expense | 413 | 848 | |||||
Asset retirement obligation accretion | 61 | 61 | |||||
Intangible asset amortization | 494 | 494 | |||||
Impairment expense | 88 | — | |||||
Severance expense | 1,019 | 211 | |||||
Variable compensation accrual adjustment | (1,473 | ) | — | ||||
Gain on sale of assets | — | (31 | ) | ||||
Transition/M&A-related expense | 98 | 158 | |||||
Litigation-related expense | — | (2 | ) | ||||
Other (income) expense | (1 | ) | 16 | ||||
Income tax expense | 86 | 28 | |||||
Non-GAAP net loss from continuing operations | $ | (6,990 | ) | $ | (2,580 | ) | |
Non-GAAP net loss from continuing operations per share, basic and diluted | $ | (0.08 | ) | $ | (0.03 | ) | |
Interest expense, net | 67 | 9 | |||||
Depreciation expense | 1,154 | 903 | |||||
Adjusted EBITDA | $ | (5,769 | ) | $ | (1,668 | ) | |
Adjusted EBITDA % | (29 | %) | (7 | %) |
Contact:
investor@emcore.com
Source: EMCORE Corporation